Landscape Capital Management L.L.C. Invests $978,000 in Indivior PLC (NASDAQ:INDV)

Landscape Capital Management L.L.C. bought a new stake in shares of Indivior PLC (NASDAQ:INDV - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 78,682 shares of the company's stock, valued at approximately $978,000. Landscape Capital Management L.L.C. owned approximately 0.06% of Indivior at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Kazazian Asset Management LLC acquired a new stake in shares of Indivior during the 4th quarter valued at about $1,706,000. Amundi boosted its holdings in shares of Indivior by 12.2% during the 4th quarter. Amundi now owns 174,434 shares of the company's stock worth $2,109,000 after buying an additional 19,010 shares during the period. Clark Estates Inc. NY lifted its position in Indivior by 1.3% during the 4th quarter. Clark Estates Inc. NY now owns 257,400 shares of the company's stock worth $3,199,000 after acquiring an additional 3,300 shares during the last quarter. VELA Investment Management LLC boosted its stake in Indivior by 45.5% during the 4th quarter. VELA Investment Management LLC now owns 179,659 shares of the company's stock valued at $2,264,000 after purchasing an additional 56,224 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Indivior during the fourth quarter worth approximately $56,000. 60.33% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the stock. Piper Sandler cut their price objective on shares of Indivior from $16.00 to $13.00 and set an "overweight" rating for the company in a research report on Thursday, March 6th. Rodman & Renshaw started coverage on Indivior in a report on Tuesday, January 28th. They set a "buy" rating and a $16.00 price objective for the company. Finally, RODMAN&RENSHAW upgraded shares of Indivior to a "strong-buy" rating in a research report on Tuesday, January 28th.

Remove Ads

Indivior Trading Up 1.9 %

Shares of INDV traded up $0.17 during mid-day trading on Friday, hitting $9.11. 695,449 shares of the company traded hands, compared to its average volume of 927,836. The stock has a market capitalization of $1.26 billion, a price-to-earnings ratio of -26.03 and a beta of 0.93. The business has a 50-day moving average of $9.61 and a 200 day moving average of $10.35. Indivior PLC has a one year low of $7.33 and a one year high of $20.10.

Indivior (NASDAQ:INDV - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.32 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.32. The business had revenue of $298.00 million for the quarter, compared to analysts' expectations of $262.35 million. Indivior had a negative return on equity of 241.73% and a negative net margin of 3.96%. As a group, analysts anticipate that Indivior PLC will post 1.22 earnings per share for the current year.

Indivior Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.